300039Shanghai Kaibao Pharmaceutical300039 info
$0.70info2.22%24h
Global rank
Market cap$729.82M
Change 7d-3.80%
YTD Performance-23.99%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Shanghai Kaibao Pharmaceutical (300039) Stock Overview

    Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.

    300039 Stock Information

    Symbol
    300039
    Address
    No. 88 Chengpu RoadShanghai, 201401China
    Founded
    -
    Trading hours
    -
    Website
    https://www.xykb.com
    Country
    🇨🇳 China
    Phone Number
    86 21 3757 2030

    Shanghai Kaibao Pharmaceutical (300039) Price Chart

    -
    Value:-

    Shanghai Kaibao Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.6977224248262576
    N/A
    Market Cap
    $729.82M
    N/A
    Shares Outstanding
    1.05B
    N/A
    Employees
    1.38K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org